QIAGEN Expands QIAcuity Digital PCR Ecosystem with Over 3,200 Installed Units
QIAGEN N.V. announced the expansion of its QIAcuity digital PCR (dPCR) ecosystem, supporting broader...
Asan Medical Center's Heavy Ion Therapy Center Breaks Ground, Set to Open in 2031
Asan Medical Center has begun construction of a heavy ion therapy center, which is scheduled to open...
Icelandic Biotech Company Alvotech Announces $152 Million Financing
Alvotech (NASDAQ: ALVO; ALVO-SDB) announced the pricing of its underwritten public offering of 22,66...
EU Proposes Biotech Act to Balance Patent Protection and Generic Competition
The European Union plans to introduce the Biotech Act to enhance the global competitiveness of Europ...
U.S. BioSTL Global Partners with UK NHS Health Innovation Networks to Help British Digital Health Companies Establish in St. Louis
BioSTL Global, the international arm of BioSTL, has reached agreements with multiple health innovati...
Canada's Toboggan Labs Partners with Mila to Advance Healthcare AI
Toboggan Labs has announced a partnership with Mila, the Quebec-based artificial intelligence instit...
Harbour BioMed and BioMap to Jointly Establish AI Pipeline R&D Company
On June 15, Harbour BioMed and BioMap jointly announced a multi-level, long-term comprehensive strat...
Cleveland Clinic and IBM Co-Host Forum Showcasing Advances in Quantum Computing and AI in Healthcare
The third annual Cleveland Discovery and Innovation Forum, co-hosted by Cleveland Clinic and IBM, wa...
BetterAge Appoints Chief Partnership Officer, Expands CTO Role
BetterAge announced two leadership changes, with Jennifer Goldberg joining as Chief Partnership Offi...
Guangzhou Atom High-Tech and Guangdong Radiation Protection Association Advance Fluorine-18 Drug Standards
Guangzhou Atom High-Tech Isotope Pharmaceutical Co., Ltd. recently exchanged views with the Guangdon...
University of Washington team develops portable bedside PET for real-time imaging in interventional procedures
Introducing molecular imaging information into interventional radiology procedures can help improve ...
U.S. FDA Approves KEYTRUDA in Combination with WELIREG for Adjuvant Treatment of Renal Cell Carcinoma
The U.S. FDA has approved KEYTRUDA (pembrolizumab) and KEYTRUDA QLEX (pembrolizumab with berahyaluro...
South Korea's Rznomics Announces Interim Clinical Data for RZ-001 in Treating rGBM
Rznomics' RNA editing-based anticancer gene therapy, RZ-001 (Taspitimagene advec), has demonstrated ...
Ascendis Reports 182-Week Data for YORVIPATH in Hypoparathyroidism
Danish biopharmaceutical company Ascendis Pharma A/S (Nasdaq: ASND) announced 182-week data from the...
Saudi KFSH Unveils AI Healthcare Solutions at HLTH Europe
King Faisal Specialist Hospital & Research Centre (KFSH) emphasized at HLTH Europe 2026 that the val...
U.S. FDA Approves Roche's PTEN Test for Companion Diagnosis in Prostate Cancer
The U.S. Food and Drug Administration (FDA) has approved the VENTANA PTEN (SP218) RxDx assay for mar...
Colombia Passes Bill to Authorize Local Production of Cancer Treatment Radiopharmaceuticals
Colombia's Congress has passed a new bill authorizing the domestic production of radiopharmaceutical...
Philippine Department of Science and Technology Showcases Three New Biomedical Research Initiatives
The Philippine Department of Science and Technology (DOST), through its Philippine Council for Healt...
University College Dublin Discovers Cinquefoil Extract Can Inhibit Superbugs
A research team at University College Dublin has found that cinquefoil extract can effectively inhib...
Netherlands completes world's first in vivo CRISPR Phase III trial, reducing attacks by 87%
The research team has successfully completed the world's first Phase III trial of an in vivo CRISPR ...
Mayo Clinic AI Model Identifies Over 90% of Primary Aldosteronism Patients
Researchers from the Mayo Clinic and other institutions have developed an artificial intelligence (A...
Mayo Clinic AI Model Identifies Over 90% of Primary Aldosteronism Patients
Researchers from the Mayo Clinic and other institutions have developed an artificial intelligence (A...
US HeroMD Launches 4-MAX Formula, Starting at $3 Per Dose
US-based telemedicine platform HeroMD has launched a compounded prescription sublingual formula, 4-M...
U.S. Celldex Announces Positive Phase 1 Results for CDX-622
U.S. biopharmaceutical company Celldex (NASDAQ: CLDX) presented positive results from a Phase 1 stud...
US-based Parabilis Medicines Sets Drug Developer Fundraising Record with $770 Million IPO
Parabilis Medicines (Nasdaq: PBLS) became the largest IPO in drug developer history last week throug...
Legend Biotech's LB2501 Achieves 100% ORR in High-Dose Cohort in Phase 1 Trial
Legend Biotech Corporation presented Phase 1 clinical proof-of-concept data (Abstract #LB5006) for i...
Japan's NovAccel Plans to Build Factory by 2028 for Mass Production of Actinium-225, Aiming for Global Top Three
Japanese startup NovAccel has announced plans to establish its own factory in eastern Japan around f...
China's Ascentage Pharma Announces 17 Clinical Updates at EHA2026
Ascentage Pharma Group (NASDAQ: AAPG; HKEX: 6855) announced 17 clinical updates on its core assets, ...
Australia launches $146.1 million hospital-based medical discovery center
Australia inaugurated its first hospital-based medical discovery center, the Aikenhead Centre for Me...
China's MGI Launches Partner Program at ESHG 2026, 27 T7+ Units Installed
MGI Tech Co., Ltd. (MGI) showcased its latest advancements in sequencing, automation, and clinical g...